FDA Inspection 1297380 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on December 12, 2025 in City Of Industry, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- City Of Industry, CA (United States)